Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 1
2000 4
2001 2
2002 4
2003 6
2004 3
2005 5
2006 5
2007 7
2008 5
2009 5
2010 4
2011 7
2012 10
2013 4
2014 4
2015 4
2016 4
2017 5
2018 3
2019 4
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 16129872

96 results
Results by year
Filters applied: . Clear all
Page 1
Metformin's contraindications: needed for now.
Fantus IG. Fantus IG. CMAJ. 2005 Aug 30;173(5):505-7. doi: 10.1503/cmaj.050401. CMAJ. 2005. PMID: 16129872 Free PMC article. No abstract available.
Metformin's contraindications should be contraindicated.
McCormack J, Johns K, Tildesley H. McCormack J, et al. CMAJ. 2005 Aug 30;173(5):502-4. doi: 10.1503/cmaj.045292. CMAJ. 2005. PMID: 16129871 Free PMC article. Review. No abstract available.
Using metformin in the presence of renal disease.
Chowdhury TA, Wright R, Yaqoob MM. Chowdhury TA, et al. BMJ. 2015 Apr 14;350:h1758. doi: 10.1136/bmj.h1758. BMJ. 2015. PMID: 25873532 No abstract available.
[Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
Pinto D, Heleno B, Gallego R, Santos I, Santiago LM, Maria V. Pinto D, et al. Acta Med Port. 2011 Mar-Apr;24(2):331-8. Epub 2011 May 20. Acta Med Port. 2011. PMID: 22011607 Free article. Portuguese.
Patients with Type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation.
Rakovac I, Jeitler K, Gfrerer RJ, Habacher W, Seereiner S, Mrak P, Pieber TR; FQSD Austria. Rakovac I, et al. Diabet Med. 2005 May;22(5):662-4. doi: 10.1111/j.1464-5491.2005.01478.x. Diabet Med. 2005. PMID: 15842528 No abstract available.
To: Holstein A, Stumvoll M (2005) Contraindications can damage your health--is metformin a case in point? Diabetologia 48:2454-2459.
Ma RC, Chow CC, Tong PC, Chan JC, Cockram CS. Ma RC, et al. Diabetologia. 2006 May;49(5):1127-8. doi: 10.1007/s00125-006-0167-x. Epub 2006 Mar 25. Diabetologia. 2006. PMID: 16565848 No abstract available.
Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin.
Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Eurich DT, et al. Arch Intern Med. 2011 Jun 13;171(11):1042-3; author reply 1043. doi: 10.1001/archinternmed.2011.224. Arch Intern Med. 2011. PMID: 21670379 No abstract available.
The FDA Revises Restrictions on Metformin Use in Kidney Impairment.
Aschenbrenner DS. Aschenbrenner DS. Am J Nurs. 2016 Aug;116(8):22-3. doi: 10.1097/01.NAJ.0000490173.76651.27. Am J Nurs. 2016. PMID: 27466921 No abstract available.
[Toxicity of metformin, pro- or con- a future restriction to its contraindications?].
Wakim El Khoury J, Décosterd D. Wakim El Khoury J, et al. Rev Med Suisse. 2013 Aug 14;9(394):1473-7. Rev Med Suisse. 2013. PMID: 24024392 French.
Contraindications can damage your health--is metformin a case in point?
Holstein A, Stumvoll M. Holstein A, et al. Diabetologia. 2005 Dec;48(12):2454-9. doi: 10.1007/s00125-005-0026-1. Epub 2005 Nov 11. Diabetologia. 2005. PMID: 16283245
96 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback